Drugmaker Mallinckrodt struck a deal to buy Endo in an effort to build a diversified pharmaceuticals company with a hefty U.S ...

Cramer stated on Mad Money at the end of last week's trading that Recursion's stock performance has "been disastrous" since ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic ...

The U.S. Food and Drug Administration (FDA) issued a warning on Friday, advising consumers against inhaling products ...

A documentary on the deaths of thousands of elderly nursing home residents denied hospital care in Spain's Madrid region ...

Company expects to submit New Drug Application (NDA) in April 2025 - DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- Eton ...

ANI Pharmaceuticals (ANIP) announced that the U.S. FDA has approved an expanded label for Iluvien that includes an indication for the treatment ...

"We've never seen him that far underwater and upside down in terms of approval and disapproval on this issue in his entire ...

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmaceutical company that has been developing a treatment ...

The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis ...

President Donald Trump’s use of tariffs has forged a rare bipartisan alliance among Kentucky’s top leaders — Democratic Gov.

We recently published a list of What Did Jim Cramer Say About These 19 Stocks Recently? In this article, we are going to take ...